Alcohol-Related Disorders Completed Phase 2 / 3 Trials for Venlafaxine (DB00285)

IndicationStatusPhase
DBCOND0027892 (Alcohol-Related Disorders)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00248612Psychosocial and Medication Treatment for Anxiety in AlcoholismTreatment